Both in Pharmaceuticals
Royalty Pharma vs ZOETIS
Over the past year RPRX returned +79.0% and ZTS returned −44.7%; their daily moves had a correlation of 0.13.
RPRX +79.0% ZTS −44.7%Growth of $1, one year, split-adjusted
| Metric | RPRX | ZTS |
|---|---|---|
| Price | $67.18 | $79.72 |
| Market cap | $29.91B | $32.94B |
| Today | +1.90% | +1.17% |
| 1 month | +16.6% | +15.4% |
| 6 months | +35.8% | −30.2% |
| Year to date | +73.9% | −36.6% |
| 1 year | +83.2% | −44.6% |
| Revenue growth (YoY) | +16.5% | −0.2% |
| Gross margin | 100.0% | 72.7% |
| Net margin | 2.7% | 28.0% |
| P/E (TTM) | 36.7× | 12.6× |
| Price / sales | 11.8× | 3.5× |
| Net cash | -$8.23B | -$7.37B |
| Dividend yield | 1.40% | 2.66% |
| Volatility (60d) | 24.9% | 30.8% |
| Short % of float | 2.9% | 4.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).